Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $1.7 million.

  • Ekso Bionics Holdings' Cost of Revenue fell 1260.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 1263.92%. This contributed to the annual value of $8.4 million for FY2024, which is 854.35% down from last year.
  • Ekso Bionics Holdings' Cost of Revenue amounted to $1.7 million in Q3 2025, which was down 1260.42% from $1.7 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Cost of Revenue high stood at $2.5 million for Q4 2023, and its period low was $1.6 million during Q1 2022.
  • Over the past 5 years, Ekso Bionics Holdings' median Cost of Revenue value was $1.8 million (recorded in 2022), while the average stood at $2.0 million.
  • Per our database at Business Quant, Ekso Bionics Holdings' Cost of Revenue tumbled by 2884.92% in 2021 and then skyrocketed by 3302.55% in 2023.
  • Ekso Bionics Holdings' Cost of Revenue (Quarter) stood at $2.0 million in 2021, then dropped by 4.66% to $1.9 million in 2022, then rose by 27.4% to $2.5 million in 2023, then dropped by 4.12% to $2.4 million in 2024, then dropped by 29.38% to $1.7 million in 2025.
  • Its Cost of Revenue stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.